Your shopping cart is empty!

COVID-19 Antigen Rapid Test

  • COVID-19 Antigen Rapid Test

InnoScreenTM COVID-19 Antigen Rapid Test

Nasal Swabs - Made in Australia

  • TGA approved. ARTG 336146
  • Results in 15 minutes
  • Built-in assay control in each test
  • Room temperature storage of kits
  • Box of 20 tests


A total of 1437 clinical specimens were collected in the study, including 638 nasopharyngeal swabs and 799 oropharyngeal swabs, to verify the performance of the COVID-19 Antigen Rapid Test Device. 240 specimens were confirmed positive, and 1197 specimens were confirmed negative by RT-PCR. InnoScreenTM COVID-19 Antigen Rapid Test Device has relative sensitivity of 98.80% (95% CI: 93.47% to 99.97%) for patients with post-onset of symptoms between 0 to 7 days and relative sensitivity of 75.16% (95% CI: 67.64% to 81.70%) for asymptomatic patients and patients post-onset of symptoms for more than 7 days. The overall specificity of InnoScreenTM COVID-19 Antigen Rapid Test Device is 99.25% (95% CI: 98.58%-99.66%).

  • Product Code: AESCOV-23/1
  • Availability: In Stock

Can we help?

Looking for a particular product? We can email or call you to assist.
Invalid Input
please check the box